Introduction
============

Endometrial cancer is a malignant tumor in the female reproductive system with a high incidence rate, accounting for approximately 25% of all the female reproductive system tumors, and its incidence in developed countries (ranking fourth) is higher than that in developing countries (ranking seventh) ([@b1-ol-0-0-9250]--[@b2-ol-0-0-9250]). Endometrial cancer often occurs in perimenopausal and postmenopausal women ([@b3-ol-0-0-9250]), and a present investigation report has shown that the age of patients at the onset of endometrial cancer becomes smaller and smaller ([@b4-ol-0-0-9250]). Although the five-year survival rate of patients has improved with the development of medical technology, the prognosis of some endometrial cancer patients is poor, causing death ([@b5-ol-0-0-9250],[@b6-ol-0-0-9250]); thus, the early diagnosis of endometrial cancer patients is crucial. The mortality rate of patients with endometrial cancer in the advanced stage is much higher than that of patients in the early stage ([@b7-ol-0-0-9250]). Improving the specificity and sensitivity of the diagnosis of endometrial cancer patients is an important means to improve the survival rate of patients.

Ultrasound plays an extremely important role in the diagnosis of tumors. Ultrasound has many advantages such as noninvasiveness, high diagnostic sensitivity, no radioactivity and simple methods. It has been widely used in the diagnosis of tumors ([@b8-ol-0-0-9250],[@b9-ol-0-0-9250]). In addition, ultrasound can reduce the invasive examination for patients and risks of invasive operation for patients through its initial screening ([@b10-ol-0-0-9250]). Tumor abnormal protein (TAP) is a kind of abnormal glycoprotein and calmodulin complex expressed after the mutation of oncogenes and tumor suppressor genes in cells ([@b11-ol-0-0-9250]). It has been reported that abnormal glycoproteins are closely related to the occurrence, development, invasion, metastasis and prognosis of cancers ([@b12-ol-0-0-9250]). Therefore, the detection of TAP in serum can provide an important reference for the clinical diagnosis of tumors.

In the present study, 248 patients with suspected endometrial cancer who were admitted to the Gynecology Department of The Second People\'s Hospital of Liaocheng (Linqing, China) from September 2013 to September 2015 were selected, and the diagnostic accordance rate of TAP combined with vaginal ultrasound was analyzed.

Materials and methods
=====================

### Clinical data

A total of 248 women patients (average age of 41.6±11.6 years) with suspected endometrial cancer who were admitted to the Gynecology Department of The Second People\'s Hospital of Liaocheng from September 2013 to September 2015 were selected and randomly divided into the control (n=124) and the observation group (n=124). The control group received conventional ultrasound examination; the observation, underwent TAP combined with conventional ultrasound examination, and all patients were definitely diagnosed by hysteroscopy and diagnostic curettage examination. Patients without tumor history, without liver, kidney and other organ dysfunction, and without abnormal hemorrhage or coagulation dysfunction before operation were included. Patients with unqualified curettage specimens, receiving treatment before, with excessive large tumor mass or with other pulmonary or chest wall diseases were excluded. This study was approved by the Ethics Committee of the Second People\'s Hospital of Liaocheng, and patients or their family members signed informed consent.

### Instruments and methods

Hitachi Hivision Avivs color Doppler ultrasound diagnostic machine (Hitachi, Ltd., Tokyo, Japan) was applied for conventional ultrasound examination so as to observe patients\' tumor diameter, shape, edge status, internal echo information and whether there were space occupying lesions. At the same time, the fasting whole blood was collected from the included patients in the early morning, and TAP detection was conducted. Abnormal carbohydrate chain glycoprotein detection kits were purchased from Thermo Fisher Scientific, Inc., (Waltham, MA, USA), and the image analyzer for TAP detection was purchased from Zhejiang Aicor Medical Technology Co., Ltd. (Zhejiang, China).

### Statistical analysis

The experimental results were analyzed by using SPSS 22.0 software (IBM Corp., Armonk, NY, USA), and the analysis of variance followed by post hoc test (Least Significant Difference) was used for compari-sons among multiple groups. Count data were expressed as percentage and detected by χ^2^ test. The sensitivity and specificity of conventional ultrasound and TAP combined with conventional ultrasound in the diagnosis of endometrial cancer were calculated, respectively. T0he diagnostic values of conventional ultrasound and the combination of the two methods in the diagnosis of endometrial cancer were studied by using the receiver operating characteristic (ROC) curve. P\<0.05 was considered to indicate a statistically sgnificant difference.

Results
=======

### Basic data

In this study, 248 patients at an average age of 41.6±11.6 years with suspected endometrial cancer were included. After the pathological diagnosis by curettage, it was found that there were 60 cases of endometrial polyps, 96 of endometrial hyperplasia, 17 of uterine fibroids and 75 cases of endometrial cancer. In addition, the menopause data of patients were collected, in which there were 43 premenopausal patients (17.34%), confirming that the age of patients at the onset of endometrial cancer becomes smaller ([Table I](#tI-ol-0-0-9250){ref-type="table"}).

### Diagnostic results of the two programs

Of 248 patients receiving hysteroscopy and diagnostic curettage examination, there were 75 patients with early-stage endometrial cancer and 173 benign patients (including 60 patients with endometrial polyps, 96 with endometrial hyperplasia and 17 with uterine fibroids). The total diagnostic accordance rate of conventional ultrasound for endometrial lesions was 87.90% (n=218), and for early-stage endometrial carcinoma was 90.67% (n=68). For patients with endometrial polyps, the rate was 88.33% (n=53); with endometrial hyperplasia was 87.50% (n=84); with uterine fibroids was 76.47% (n=13). For TAP combined with vaginal ultrasound for endometrial lesions, the rate was 94.35% (n=234), and for early-stage endometrial cancer was 94.67% (n=71). For diagnosis for patients with endometrial polyps the rate was 95.00% (n=57), with endometrial hyperplasia it was 93.75% (n=90), and with uterine fibroids it was 94.12% (n=16); The diagnostic accordance rates of TAP combined with conventional ultrasound for endometrial lesions were higher than those of simple conventional ultrasound (P\<0.05) ([Table II](#tII-ol-0-0-9250){ref-type="table"}). Imaging manifestations of conventional ultrasound ([Table III](#tIII-ol-0-0-9250){ref-type="table"}).

### TAP detection results

The image analyzer for TAP detection was used to analyze the polarity of TAP detection results, which showed that the positive rate of TAP detection was 86.67% (n=65) in patients with endometrial cancer and 4.37% (n=8) with benign lesions; there was a significant difference between the two groups of patients (P\<0.05). Among the patients with benign lesions and positive TAP detection results, there were 5 cases of uterine fibroids, 2 of endometrial polyps and 1 of endometrial hyperplasia ([Fig. 1](#f1-ol-0-0-9250){ref-type="fig"}).

### Sensitivity and specificity of the two programs

The sensitivity and specificity of conventional ultrasound to endometrial cancer were 85.7 and 89.7%, respectively, and those of TAP combined with vaginal ultrasound to endometrial cancer were 90.0 and 92.8%, respectively. ROC analysis results revealed that the AUC of convention ultrasound in the diagnosis of endometrial cancer was 0.754 \[95% confidence interval (CI): 0.211--2.534\], and that of TAP combined with vaginal ultrasound in the diagnosis of endometrial cancer was 0. 814 (95% CI: 0.517--0.932); the difference between the two programs was significant (P=0.011) ([Fig. 2](#f2-ol-0-0-9250){ref-type="fig"}).

Discussion
==========

Prognoses of endometrial cancer in the advanced stage and some special cases of endometrial cancer are very poor, and their 5-year survival rates are relatively low, so the early diagnosis of patients with endometrial cancer is very necessary ([@b6-ol-0-0-9250],[@b7-ol-0-0-9250]). TAP is a type of complex that is expressed and released by tumor cells and can be found in the blood of tumor patients, which provides a very convenient specimen for the early screening of tumors ([@b13-ol-0-0-9250],[@b14-ol-0-0-9250]). TAP has become a hot research object for researchers, especially on the screening and early diagnosis of tumors, since it was discovered by the Union of Soviet Socialist Republics (USSR) scholars, Kostyantin, A. and Galakhin ([@b15-ol-0-0-9250],[@b16-ol-0-0-9250]). However, there are few diagnostic studies in patients with endometrial cancer in the early stage. This study was expected to provide a basis for clinical diagnosis of endometrial cancer in the early stage and improve the survival rate of patients.

In the present study, 248 patients with suspected endometrial cancer were included, and with other tumors were excluded. TAP combined with conventional ultrasound was used for diagnosis, whose results were compared with those of diagnostic curettage detection, so as to analyze the value of TAP combined with conventional ultrasound in the diagnosis of endometrial cancer in the early stage. The study\'s results showed that the diagnostic accordance rate of TAP for patients with endometrial cancer was 86.67%, and that of conventional ultrasound for patients with endometrial cancer was 90.67%, and that of the combination of the two was 94.35%; the diagnostic accordance rate of TAP and conventional ultrasound for patients with endometrial cancer were lower than that of the combination of the two (P\<0.05), indicating that TAP detection can improve the diagnostic effect of conventional ultrasound on endometrial cancer. In addition, ROC curve results also revealed that the combined diagnostic method had a high diagnostic value (AUC=0.814). The sensitivity of the TAP detection system is the expressed TAP when the number of tumor cells reaches 100,000 and above, but it takes about one year for the number of tumor cells to proliferate to 100,000 before the tumor has not formed a mass, which is extremely important for the treatment and survival of patients, especially of those with malignant tumors with fast development and poor prognosis ([@b17-ol-0-0-9250]--[@b20-ol-0-0-9250]). There are few researchers studying the effect of TAP detection in the diagnosis of endometrial cancer in the early stage, so the conclusions in this study still need to be further validated. This study also had its advantages: All patients with past tumor history were excluded to avoid the interference in TAP detection; a self-controlled test was conducted so that the interference of test samples was avoided. TAP is also used in many kinds of cancers, such as gastric, thyroid and colorectal cancer, and it is of positive significance in improving the accordance rate of tumor diagnosis ([@b21-ol-0-0-9250]--[@b22-ol-0-0-9250]). These indirectly confirmed the diagnostic value of TAP in the diagnosis of endometrial cancer. Benign endometrial lesions were also analyzed, which showed that approximately 20--40% of patients suffered from atypical endometrial hyperplasia before the onset of endometrial cancer. TAP combined with vaginal ultrasound also has a relatively diagnostic high accordance rate (93.75%) for endometrial hyperplasia, and among patients with TAP positive detection results, there was 1 case of endometrial hyperplasia. Due to the limitation of experimental time, the patients were not followed-up, and further investigation is needed for confirmation of the results.

In summary, TAP combined with transvaginal ultrasound in the diagnosis of early-stage endometrial cancer has a higher accuracy rate, and it is worth promoting and applying in clinical practice.
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###### 

Clinical data of patients.

  Clinical data                 Control group (n=124)
  ----------------------------- -----------------------
  Age (years)                   41.6±11.6
  Definite diagnostic results   
    Endometrial polyps          60
    Endometrial hyperplasia     96
    Uterine fibroids            17
    Endometrial cancer          75
  Nationality n (%)             
    Han                         219 (88.31)
    National minority           29 (11.69)
  Place of residence n (%)      
    City                        165 (66.53)
    Countryside                 83 (33.47)
  Menopausal status n (%)       
    Premenopause                43 (17.34)
    Postmenopause               205 (82.66)

###### 

Diagnostic accordance rates of TAP combined with conventional ultrasound and conventional ultrasound.

  Rate                                         Conventional ultrasound   TAP combined with conventional ultrasound   P-value
  -------------------------------------------- ------------------------- ------------------------------------------- ---------
  Total diagnostic accordance rate             218 (87.90)               234 (94.35)                                 0.031
  Accordance rate of endometrial cancer        68 (90.67)                71 (94.67)                                  0.047
  Accordance rate of endometrial hyperplasia   84 (87.50)                90 (93.75)                                  0.032
  Accordance rate of endometrial polyps        53 (88.33)                57 (95.00)                                  0.024
  Accordance rate of uterine fibroids          13 (76.47)                16 (94.12)                                  0.017

###### 

Imaging manifestations of conventional ultrasound.

                                          Endometrial polyps                  Endometrial hyperplasia                     Uterine fibroids                                   Endometrial cancer
  --------------------------------------- ----------------------------------- ------------------------------------------- -------------------------------------------------- ------------------------------------------------------
  Uterine volume                          No obvious increase                 No obvious change; increase in some parts   Increased                                          Obviously increased
  Echo                                    Hypoecho Equal echo Hyperecho       Slightly enhanced                           Hypoecho; hyperecho in tiny minority               Unevenly thickened
  Intimal thickness change                No significant                      Thickened                                   Thickened                                          Thickened
  Lesion border                           Clear                               Clear uterine cavity line                   Relatively clear                                   Rough surface; some unclear or even vanished borders
  Lesion area liquidation/calcification   Calcification in few lesion areas   No liquidation/calcification                Liquidation/calcification on in few lesion areas   Liquidation in some lesion areas
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